| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6056941 | BRACCO | Kit for the preparation of technetium TC 99m teboroxime myocardial perfusion agent |
Jul, 2019
(4 years ago) | |
Cardiotec is owned by Bracco.
Cardiotec contains Technetium Tc-99M Teboroxime Kit.
Cardiotec has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Cardiotec are:
- US6056941
Cardiotec was authorised for market use on 19 December, 1990.
Cardiotec is available in injectable;injection dosage forms.
The generics of Cardiotec are possible to be released after 28 July, 2019.
Drugs and Companies using TECHNETIUM TC-99M TEBOROXIME KIT ingredient
Market Authorisation Date: 19 December, 1990
Treatment: NA
Dosage: INJECTABLE;INJECTION
More Information on Dosage
CARDIOTEC family patents
